2Joseh SB,Roger IG,Ivanoff B,et al.Current status and future priorities for rotavirus vaccine developing,evaluation and implementation in developing countries[J].Vaccine,1999,17:2207 - 2222.
2Djuretic T, Ramsay M, Gay N, et al. An estimate of the proportion of diarrhea disease episodes seen by general practitioners attributable to rotavirus in children under 5 y of age in England and Wales. Acta Paediatric, 1999,426(suppl)∶38-41.
3Roger IG, Paul EK, Robert CH, et al. The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. J Infect Dis, 1996,174(suppl 1)∶s5-s11.〗
4Cook SM, Glass RI, LeBaron CW, et al. Global seasonality of rotavirus infection. Bull WHO, 1999, 68∶171-177.
5Joseph SB, Roger IG,IvanoffB, et al. Current status and future priorities for rotavirus vaccine developing, evaluation and implementation in developing countries. Vaccine, 1999, 17∶2207-2222.
6Bresee JS, Glass RI, Parashar UD, et al. Disease states and vaccines: rotavirus. In: Bloom BR, Lambert PH,eds. The Vaccine Book. Academic Press, New York, 2002.225-243.
7Koopmans M, Brown D. Seasonality and diversity of group A rotaviruses in Europe. Acta Paediatric, 1999,426(suppl)∶14-19.
8Fang ZY, Yang H, Zhang J, et al. Child rotavirus infection in association with acute gastroenteritis in two Chinese sentinel hospitals. Pediatrics International,2000,42∶401-405.
9Fang ZY, Yang H, Qi J, et al. Diversity of rotavirus strains among children with acute diarrhea in China: 1998-2000 surveillance study. J Clin Microbiol, 2002,40∶1875-1878.
10Gentsch JR, Woods PA, Ramachandran M, et al. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis, 1999, 174(suppl)∶s30-s36.
